Riskpilot← Back to searchSign inGet full accessMedted AB
ABActiveOrg 5590586136Trastvägen 6Medical specialists activities · NACE 8622Est. 20160 employees
Revenue 2025
SEK 829K
+1% vs 2024
EBITDA margin
51.0%
-11% vs 2024
Equity ratio
62.1%
Financial strength
Net profit 2025
SEK 332K
-11% vs 2024
| Revenue | SEK 829K | +1% |
| EBITDA | SEK 423K | -11% |
| Net profit | SEK 332K | -11% |
| Total assets | SEK 751K | +0% |
| Equity | SEK 466K | -4% |
| Employees | 0 | — |
Legal name
Medted AB
Org number
5590586136
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 april 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget bedriver konsultativ verksamhet inom medicin, ortopedi, idrottsmedicin, hälsa, träning och stadsutveckling samt annan därmed förenlig verksamhet. Bolaget bedriver också handel med möbler.
Address
Trastvägen 6
Email
ted.eneqvist@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 272 | 247 | 691 | 823 | 829 |
| Staff expenses | — | −49 | −70 | −92 | −121 |
| EBITDA | 17 | 32 | 291 | 476 | 423 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 17 | 32 | 291 | 476 | 423 |
| Net financials | −1 | 0 | −0 | 0 | 2 |
| Profit before tax | 15 | 32 | 291 | 476 | 425 |
| Tax | −3 | −7 | −67 | −101 | −93 |
| Net profit | 12 | 25 | 224 | 375 | 332 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 249 | 232 | 537 | 750 | 751 |
| Equity | 160 | 185 | 409 | 484 | 466 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 89 | 47 | 128 | 266 | 285 |
| Total debt | 89 | 47 | 128 | 266 | 285 |
EBITDA margin
51.0%
This company
15.8%
Market median
+223% vs market
20212025
Equity ratio
62.1%
This company
38.2%
Market median
+63% vs market
20212025
Return on equity
71.2%
This company
18.4%
Market median
+287% vs market
20212025
Net profit margin
40.0%
This company
8.1%
Market median
+394% vs market
20212025
Asset turnover
1.10×
This company
1.12×
Market median
+2% vs market
20212025
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TO Chief Executive Officer | Chief Executive Officer | 2022 |
EM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medted AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ted Ove Eneqvist | Chief Executive Officer | 0 companies |
| Erica Maria Eneqvist | Deputy Chief Executive Officer | 0 companies |